Mwiza Ushe is a Neurology physician. OpenAlex indexes 37 publications with 684 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Barnes Jewish Hospital Plz
Div Neurology Movement Disorders
Saint Louis, MO 631101003
Telephone
314-362-1408Registry record last updated 17 Apr 2025.
Clinical trials
- Clinical Outcomes for Deep Brain Stimulation
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Abbott LaboratoriesProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
95.7%Neuromuscular Blocker95.6%Onabotulinumtoxina100%Part B, office-administered≥64 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D≥13 patientsNervous system
4.1%Aromatic Amino Acid Decarboxylation Inhibitor1.6%Carbidopa-Levodopa75%Carbidopa-Levodopa Er22%Rytary3%Part D<11 patientsSSRI0.5%Escitalopram Oxalate31%Trazodone Hcl18%Paroxetine Hcl14%Sertraline Hcl14%Fluoxetine Hcl13%Citalopram Hbr8%Part D<11 patients+ 15 more classes in this area
Cardiovascular
0.1%Beta blocker0.1%Propranolol Hcl100%Part D≥13 patientsalpha-Adrenergic Agonist0%Midodrine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Functional Connectivity and Volumetrics Improve Outcome Prediction for Deep Brain Stimulation in Parkinson's Disease
Movement Disorders Clinical Practice
2025 - Differentiating effects of levodopa and subthalamic nucleus deep brain stimulation on motor features in Parkinson disease
Clinical Parkinsonism & Related Disorders
2025 - Long‐Term Outcome of Unilateral Magnetic Resonance Imaging–Guided Focused Ultrasound for Fragile X Tremor Ataxia Syndrome
Movement Disorders Clinical Practice
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”